Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cell Metabolism

• Publication date

  2009-04-08

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.cmet.2009.02.006PMID 19356714PMCID PMC2668535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromatin remodeling, metabolism and circadian clocks: the interplay of CLOCK and SIRT1.

  2009cited by this paper
• SirT1 gain of function increases energy efficiency and prevents diabetes in mice.

  2008cited by this paper
• Tissue-specific regulation of SIRT1 by calorie restriction.

  2008cited by this paper
• Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism.

  2008cited by this paper
• The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control.

  2008cited by this paper
• A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange

  2008cited by this paper
• Sirt1 protects against high-fat diet-induced metabolic damage

  2008cited by this paper
• Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.

  2007cited by this paper
• Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation.

  2007cited by this paper
• Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling

  2007cited by this paper
• Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

  2007cited by this paper
• Genetic links between diet and lifespan: shared mechanisms from yeast to humans

  2007cited by this paper
• Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

  2007cited by this paper
• SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

  2007cited by this paper
• Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1

  2007cited by this paper
• Resveratrol improves health and survival of mice on a high-calorie diet

  2006cited by this paper
• Sirtuins as potential targets for metabolic syndrome

  2006cited by this paper
• LXRS and FXR: the yin and yang of cholesterol and fat metabolism.

  2006cited by this paper
• Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

  2006cited by this paper
• Nuclear receptor expression links the circadian clock to metabolism.

  2006cited by this paper
• MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

  2006cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

  2005cited by this paper
• Retinoid x receptor heterodimers in the metabolic syndrome.

  2005cited by this paper
• SIRT1 Regulates HIV Transcription via Tat Deacetylation

  2005cited by this paper
• Inflammation, stress, and diabetes.

  2005cited by this paper
• Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

  2005cited by this paper
• FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction.

  2005cited by this paper
• Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase

  2004cited by this paper
• Mammalian SIRT1 represses forkhead transcription factors.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• The Sir2 family of protein deacetylases.

  2004cited by this paper
• Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

  2004cited by this paper
• Molecular mediators of hepatic steatosis and liver injury.

  2004cited by this paper
• Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

  2004cited by this paper
• Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease*

  2004cited by this paper
• Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase

  2004cited by this paper
• Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

  2004cited by this paper
• Increasing prevalence of the metabolic syndrome among u.s. Adults.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice

  2003cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• The Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis

  2003cited by this paper
• The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis.

  2003cited by this paper
• A central role for JNK in obesity and insulin resistance

  2002cited by this paper
• Nuclear receptors and lipid physiology: opening the X-files.

  2001cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• CREB regulates hepatic gluconeogenesis through the coactivator PGC-1

  2001cited by this paper
• Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Defect in Peroxisome Proliferator-activated Receptor α-inducible Fatty Acid Oxidation Determines the Severity of Hepatic Steatosis in Response to Fasting*

  2000cited by this paper
• A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.

  2000cited by this paper
• The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.

  2000cited by this paper
• Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.

  2000cited by this paper
• Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

  2000cited by this paper
• The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes

  2000cited by this paper
• Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

  2000cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  1999cited by this paper
• Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

  1999cited by this paper
• Peroxisome Proliferator-induced Long Chain Acyl-CoA Thioesterases Comprise a Highly Conserved Novel Multi-gene Family Involved in Lipid Metabolism*

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor alpha as the mediator of polyunsaturated fatty acid regulation of s14 gene transcription.

  1996cited by this paper
• A simple enzymatic quantitative analysis of triglycerides in tissues.

  1992cited by this paper
• The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism.

  1991cited by this paper
• The role of the liver in metabolic homeostasis: Implications for inborn errors of metabolism

  1991cited by this paper
• Identification and Characterization of Pancreatic Eukaryotic Initiation Factor 2 a -Subunit Kinase, PEK, Involved in Translational Control

  year unknowncited by this paper

• Unveiling MASH: A Comprehensive Review Highlighting Experimental Insights, Molecular Pathogenesis, and Therapeutic Approaches.

  2026cites this paper
• Coordinating metabolic reprogramming and exosome secretion: A dual role for SIRT1/HIF-1α under hypoxia in golden pompano

  2026cites this paper
• Modulation of SIRT1/PPARγ pathways and tight junction proteins by nicotinamide riboside under chronic variable stress

  2026cites this paper
• Interventions for animal hazards caused by micro/nano plastics exposure: a systematic review

  2026cites this paper
• Molecular insights into the antimicrobial and cardiometabolic functions of Lactobacillus crispatus isolated from the reproductive tract microbiota of Indian women

  2026cites this paper
• HINT2-Mediated Mitochondrial Modulation Contributes to G-CSF Neuroprotection in Alcohol Use Disorder-Related Ischemic Stroke

  2025cites this paper
• Hepatoprotective effects of polysaccharide from Morchella esculenta are associated with activation of the AMPK/Sirt1 signaling pathway in mice with NAFLD.

  2025cites this paper
• The Role of microRNA-22 in Metabolism

  2025cites this paper
• Metabolic reprogramming in the spinal cord drives the transition to pain chronicity

  2025cites this paper
• Brunodelphinine A alleviates non-alcoholic fatty liver disease by inhibiting oxidative stress and regulating lipid metabolism via NOX4/SIRT1/PPARs axis.

  2025cites this paper
• CC Genotype at TCF7L2 Diabetes Risk Locus rs7903146 Directs a Coordinated Fatty Acid Response to a Mediterranean Diet Intervention: A Randomized Controlled Trial

  2025cites this paper
• SIRT1 in Liver Diseases: Mechanistic Insights and Therapeutic Prospects

  2025cites this paper
• The FOXO1-SIRT1 axis in ankylosing spondylitis: A cross-platform regulator linking immunometabolism, oxidative stress, and bone remodeling.

  2025cites this paper
• Alcohol-induced liver injury is mediated via α4-containing nicotinic acetylcholine receptors expressed in hepatocytes.

  2025cites this paper
• Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches

  2025cites this paper
• Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1.

  2025cites this paper
• Key Transcription Factors: Avenue for Treating Alcoholic Liver Disease

  2025cites this paper
• Beta-catenin/sirtuin 1/farnesoid X receptor pathway promotion of portal vein ligation and parenchymal transection-induced rapid liver regeneration.

  2025cites this paper
• SIRT1-Mediated Epigenetic Protective Mechanisms of Phytosome-Encapsulated Zea mays L. var. ceratina Tassel Extract in a Rat Model of PM2.5-Induced Cardiovascular Inflammation

  2025cites this paper
• Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model

  2025cites this paper
• Nobiletin potentially reduce lipid accumulation by up-regulating the SIRT1-AMPK signaling pathway in HepG2 hepatocarcinoma cells

  2025cites this paper
• Potential protective role of Lycium ruthenicum Murray polysaccharides against lipopolysaccharide-induced liver injury via mitochondrial biogenesis.

  2025cites this paper
• The epigenetic roles of pirfenidone - implication in liver disease management.

  2025cites this paper
• The clinical value of serum sirtuin-1 concentration in the diagnosis of metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Repurposing of semaglutide by targeting SIRT1 and TGF‐β/Smad signaling in hepatic fibrosis

  2025cites this paper
• Hepatocyte mitochondrial NAD+ content is limiting for liver regeneration

  2025cites this paper
• Metabolic Evaluation of a Novel Hydroxyfuranone Compound: Adiposity Reduction in Obese Mice by Increasing SIRT1 Gene Expression.

  2025cites this paper
• Metabolic reprogramming in the spinal cord drives the transition to pain chronicity

  2025cites this paper
• Pharmacological inhibition of Ubiquitin-Specific Peptidase 10 (USP10) with spautin-1 attenuates adipogenesis through CCAAT/Enhancer-Binding Protein Beta (C/EBPβ) destabilization

  2025cites this paper
• CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD

  2025cites this paper
• Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes

  2025cites this paper
• Keeping up with the nicotinamides: NADP(H), the forgotten circadian cofactor that keeps metabolic time

  2025cites this paper
• Epigenetically Mediated Health Effects of Intermittent Fasting

  2025cites this paper
• Regulation of hepatic Sirt1 expression and lipid metabolism through TNF receptor signaling

  2025cites this paper
• Salidroside protects bovine hepatocytes against fatty acid-induced lipid accumulation and inflammation by activating AMPK/SIRT1 pathway.

  2025cites this paper
• Hexaraphane Affects the Activation of Hepatic PPARα Signaling: Impact on Plasma Triglyceride Levels and Hepatic Senescence with Aging

  2025cites this paper
• Nampt as a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular and neurodegenerative diseases.

  2025cites this paper
• α-Lipoic acid alleviate myocardial infarction by suppressing age-independent macrophage senescence

  2025cites this paper
• Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Epigenetic regulation by ketone bodies in cardiac diseases and repair.

  2025cites this paper
• The role of SIRT1 in the development of gastrointestinal tumors

  2025cites this paper
• Sirtuin1 mitigation of calcium oxalate nephropathy via enhancing itaconate abundance through reduction of histone trimethylation

  2025cites this paper
• TMAO promotes disorders of lipid metabolism in psoriasis.

  2025cites this paper
• Hepatic Olfr734 Deficiency Worsens Hepatic Glucose Metabolism and Induces MASLD in Mice

  2025cites this paper
• NAD+ boosting by oral nicotinamide mononucleotide administration regulates key metabolic and immune pathways through SIRT1 dependent and independent mechanisms to mitigate diet-induced obesity and dyslipidemia in mice

  2025cites this paper
• Liver, ageing and disease

  2025cites this paper
• A crucial role of the malate aspartate shuttle in metabolic reprogramming in TNF-induced SIRS

  2025cites this paper
• Dysregulation of Hepatic AMPK and SIRT-1 Expressions Mediates Aluminum Oxide Nanoparticles-Induced Hepatic Injury and Microangiopathy in Rats with Special Emphasis on Shape-Dependent Hepatotoxicity

  2025cites this paper
• Glacium flavum‐Derived Phytochemical Compounds and Their Molecular Interactions with SIRT1

  2024cites this paper
• Saikogenin A improves ethanol-induced liver injury by targeting SIRT1 to modulate lipid metabolism

  2024cites this paper
• Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells

  2024cites this paper
• Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease

  2024cites this paper
• Effects of quinoa on cardiovascular disease and diabetes: a review

  2024cites this paper
• Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis

  2024cites this paper
• Delphinidin or α‐amyrin attenuated liver steatosis and metabolic disarrangement in rats fed a high‐fat diet

  2024cites this paper
• Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting.

  2024cites this paper
• Chronic hyperglycemia induces hepatocyte pyroptosis via Gα12/Gα13-associated endoplasmic reticulum stress: Effect of pharmacological intervention.

  2024cites this paper
• Sirt1 mitigates hepatic lipotoxic injury induced by high-fat-diet in fish through Ire1α deacetylation.

  2024cites this paper
• Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses

  2024cites this paper
• Polyoxometalates Ameliorate Metabolic Dysfunction-Associated Steatotic Liver Disease by Activating the AMPK Signaling Pathway

  2024influential citation
• 8-Prenylgenistein Isoflavone in Cheonggukjang Acts as a Novel AMPK Activator Attenuating Hepatic Steatosis by Enhancing the SIRT1-Mediated Pathway

  2024cites this paper
• SIRT1 and FOXO1 role on MASLD risk: effects of DHA-rich n-3 PUFA supplementation and exercise in aged obese female mice and in post-menopausal overweight/obese women

  2024influential citation
• Down-regulation of miR-29 improves lipid metabolism in fatty liver of dairy cows

  2024cites this paper
• Phytoestrogens and Sirtuin Activation for Renal Protection: A Review of Potential Therapeutic Strategies

  2024cites this paper
• The dual-edged role of SIRT1 in energy metabolism and cardiovascular disease.

  2024cites this paper
• Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking.

  2024cites this paper
• Role of the Histone Deacetylase Family in Lipid Metabolism: Structural Specificity and Functional Diversity.

  2024cites this paper
• Epigenetic Mechanisms and Their Role in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis

  2024cites this paper
• Analysis of mechanism, therapeutic strategies, and potential natural compounds against atherosclerosis by targeting iron overload-induced oxidative stress.

  2024cites this paper
• Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice

  2024cites this paper
• SIRT1 Controls Lipid Metabolism Under Physiological and Pathological Conditions: Implications in Atherosclerosis

  2024cites this paper
• A transcriptional regulatory mechanism of genes in the tricarboxylic acid cycle in the heart

  2024cites this paper
• SIRT1 regulates hepatic vldlr levels

  2024cites this paper
• Molecular characterization, function, tissue differential expression, and single-nucleotide polymorphism of buffalo TP53 gene

  2024cites this paper
• A High-Fat and High-Fructose Diet Exacerbates Liver Dysfunction by Regulating Sirtuins in a Murine Model

  2024cites this paper
• Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease.

  2024cites this paper
• The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum

  2024influential citation
• Piceatannol Upregulates SIRT1 Expression in Skeletal Muscle Cells and in Human Whole Blood: In Vitro Assay and a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial

  2024cites this paper
• Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health

  2024cites this paper
• Taurine Activates SIRT1/AMPK/FOXO1 Signaling Pathways to Favorably Regulate Lipid Metabolism in C57BL6 Obese Mice.

  2024cites this paper
• Effect of Borreria hispida Extract on SIRT1, HIF-1α, ET-1 and VEGFR-2 Gene Expression in NRK-52E Cells Subjected to Glucotoxicity

  2024cites this paper
• Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway.

  2024cites this paper
• Effects of Chronic Sleep Restriction on Transcriptional Sirtuin 1 Signaling Regulation in Male Mice White Adipose Tissue

  2024cites this paper
• Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model

  2024cites this paper
• Inflammatory liver diseases and susceptibility to sepsis.

  2024cites this paper
• NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice

  2024cites this paper
• GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD.

  2024cites this paper
• Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases

  2024cites this paper
• Behavior and physiology in female Cricetulus barabensis are associated with the expression of circadian genes

  2024cites this paper
• Hepatoprotective Activity and Mechanisms of Prenylated Stilbenoids.

  2024cites this paper
• Dimethyl fumarate restores Ca2+ dyshomeostasis through activation of the SIRT1 signal to treat nonalcoholic fatty liver disease.

  2024cites this paper
• Hispidulin can improve lipid parameters in the HepG2 cell line with metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review

  2024cites this paper
• Lycopene alleviates Bisphenol a-induced lipid accumulation via activating the SIRT1/PGC-1α signaling in PK15 cells

  2024cites this paper
• Vitamin D Mitigates Hepatic Fat Accumulation and Inflammation and Increases SIRT1/AMPK Expression in AML-12 Hepatocytes

  2024cites this paper
• MicroRNAs Modulating Neuroinflammation in Parkinson's disease

  2024cites this paper
• AIE‐Based Sensor Combination for Oleic Acid/Elaidic Acid Discriminating and Sensing

  2024cites this paper
• Histone Modifications in NAFLD: Mechanisms and Potential Therapy

  2023cites this paper
• Sirtuins: The NAD+-Dependent Multifaceted Modulators of Inflammation

  2023cites this paper